View Article

Abstract

One of the oldest and most important plant-based secondary metabolites utilized in cancer treatment is vinca alkaloids, which are extracted from the Catharanthus roseus plant. These chemicals, which include vindesine, vinblastine, vincristine, and vinorelbine, have a unique method of action in which they interfere with microtubule dynamics, causing malignant cells to apoptosis and cell cycle arrest. Vinca alkaloids' flexibility is proven by their usage in the therapy of haematological along with non-malignant conditions, and their role in cancer. Their biosynthesis, mode of action, pharmacological uses, and therapeutic difficulties are examined in this review. In order to reduce toxicity and improve efficacy, it also discusses new developments in synthetic modifications and drug delivery techniques. This article emphasizes the continued importance of vinca alkaloids in creating tailored cancer therapeutics by highlighting the meeting point of contemporary pharmacology and traditional medicine.

Keywords

Cancer, Alkaloids, Biosynthesis, Vinca, Catharanthus Roseus, Extraction

Introduction

Cancer ranks as one of the top reasons of death across globe. Cancer, defined as the uncontrolled, rapid generation of abnormal cells caused by various alterations in the regulation of genes is one among the primary causes of death due to illness globally.  It killed over 10 million people worldwide in 2020, with breast cancer, colon cancer, lung cancer, and rectal cancer, skin cancer, prostate cancer, and stomach cancer accounting for a high proportion of new cases (https://www.who.int/news-room/fact sheets/detail/cancer). Chemotherapy is harmful to healthy cells, and chemically generated medications, radiotherapy, and chemotherapy are now separate components of cancer treatment (Zlatian OM.et.al., 2015, Buga AM.et.al., 2019, Zijlstra A.et.al., 2019). Ninety percent of high-income nations typically offer comprehensive cancer care, whereas only fifteen percent of low-income countries do so. This results in a significant financial burden on cancer therapy (WHO, 2020). Cancer was projected to have cost the US economy $1.16 trillion in 2010 alone (Wild C. et al., 2020). However, if identified early and treated appropriately, many tumors can be cured. Eliminating associated risks while employing evidence-based preventative strategies may avoid 30 to 50 % of cancers (https://www.who.int/news-room/fact-sheets/detail/cancer). Plant secondary metabolism products are well-classified and regarded as bioactive chemicals for preventing cancer at both the primary and secondary levels. As a result, numerous pieces of data demonstrate that consuming more secondary metabolites can reduce the risk of developing cancer (Kato Y. et al., 2018). These chemicals inhibit the formation and death of microtubule assemblies in cells, as well as the regulation of metabolic and signaling pathways that drive angiogenesis. Secondary metabolites are classified into the following main categories: lignans, steroids, phenolics, terpenes, glucosides, curcumins, saponins, alkaloids along with flavonoids (Sharifi-Rad J. et al., 2022). Because these plant-based bioactive molecules offer much-needed geno-protective actions, such as preserving healthy cells from DNA damage, secondary metabolites, either individually or in groups, can be employed to construct personalized cancer prevention strategies (Islam MT.et.al.,2021, Hossain R.et.al.,2022, Salehi B.et.al., 2019). Alkaloids are a family of phytochemicals that have showed potential as anticancer agents.

Alkaloids:

Alkaloids are a varied group of chemicals; around 3000 alkaloids from plants, fungi, and mammals have been identified. Among the best-known alkaloids are nicotine and morphine. According to Kurek et al. (2019), alkaloids are low molecular weight organic nitrogenous substances that are commonly classified chemically as tropanes, quinolines, terpenoids, isoquinolines, pyrrolidines, indoles, pyrrolizidines, and steroids. The alkaloids are typically crystalline, colorless, and non-volatile (https://www.britannica.com/science/atropine). They are also thought to be more stable and less harmful. Alkaloids have been scientifically demonstrated to limit the topoisomerase enzyme, reducing cell death and DNA replication. Alkaloids has therefore served as the foundation for the development of medications for a variety of diseases, comprising anti-inflammatory, antibacterial, along with anticancer properties (Dey P. et al., 2020).Alkaloids derived from plants have been beneficial in reducing oncogenesis. Alkaloids, a varied category of organic molecules found naturally, make up the bulk of the biggest group of phytochemicals (Kurek J. et al., 2019). One important characteristic that sets alkaloids apart and contributes to their alkaline qualities and therapeutic effects is their nitrogen atoms. The majority of alkaloids are synthesized using amino acids such lysine, tyrosine, phenylalanine,  ornithine, along with tryptophan. Numerous alkaloids are produced as a result of the transformation of these precursors into a range of core intermediates. Most alkaloids have heterocyclic tertiary nitrogen in their structure, though they can take many various chemical forms. Alkaloids, which are largely generated from plants, number about 20,000. Alkaloids have also been found to be present in microorganisms and also in marine organisms such as puffer fish, dinoflagellates, as well as algae, as well as terrestrial animals like toads and insects. Alkaloids are found in plant species that have more than 0.001% alkaloids. Plant families such as Papaveraceae, Apocynaceae, Solanaceae, Amaryllidaceae, Asteraceae, Rutaceae, Fabaceae, along with Rubiaceae all have the potential for pharmacological usage.Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).

Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines,

such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic

acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014)Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic

acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014)Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).

Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole

structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and

proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines,such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014)Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes, inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanismsof action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014) Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines,such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014)Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acidsynthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes, inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrolestructures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic

acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic

acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes, inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic

acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic

acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012).Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001).Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic

acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014). Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014). Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes, inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic

acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acidsynthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014).

CLASSIFICATION:

Pyrolidine alkaloids, imidazole, tropane, indole, piperidine, purine, pyrrolizidine, quinolozidine, as well as isoquinoline are among the chemicals classified according to their heterocyclic ring system and biosynthetic precursors (Dey P. et al., 2020). Numerous researchers have classed alkaloids in different ways. One of the most often used categorization techniques divides an entire class of chemicals into three categories.

1.True Alkaloids:

True alkaloids, which include atropine and nicotine, are composed of an amino acid and a heterocyclic ring containing nitrogen.

2. Proto Alkaloids:

Proto-alkaloids include adrenaline, ephedrine, and other compounds with a nitrogen atom derived from an amino acid that is not a component of the heterocyclic ring.

3. Pseudo Alkaloids:

Caffeine, theobromine, and other substances that do not come from amino acids are known as pseudo-alkaloids (Dey P. and others, 2020).

Vinca Alkaloids:

 Vinca alkaloids are a type of organic molecule known as alkaloids. They are commonly produced by plants and are made up of hydrogen, oxygen, nitrogen and carbon.
       
            Fig No Vinblastine.png
       

Fig No Vinblastine
       
            Fig No. Vincristine.png
       

Fig No: Vincristine  

However, the name symbolizes alkali, such as those substances that don't have alkaline qualities. Despite their toxic properties, many alkaloids also have physiological effects that make them effective medications (Sahelian R. et al., 2011).Vinca alkaloids are the very old type of plant utilizing for treating cancer (Brogan C., 2010).

Source:

Vinca alkaloids are obtained from the periwinkle plant in Madagascar. The pink periwinkle plant Catharanthus roseus G. Don creates naturally occurring or partially synthetic nitrogenous bases(Kufe DW.et.al., 2003). Canadian scientists Robert Noble with Charles Beer made the initial discovery of vinca alkaloids in the 1950s.

Mechanism of Action:

Vince alkaloids' major means of cytotoxicity involve their relationships between tubulin and the disruption of microtubule function, namely of the microtubules that constitute the spindle of mitosis machinery, which culminates in metaphase arrest. They can, however, engage in a wide range of additional metabolic processes that could or might not be connected to their impact on microtubules. Many of the consequences that do not involve microtubule breakdown become apparent only after cells have undergone treated with clinically modest concentrations of vinca alkaloids. However, because microtubules play a role in a variety of non-mitotic processes, vinca alkaloids and other antimicrotubule medications affect both malignant and non-malignant cells throughout the non-mitotic cycle. Vinca alkaloids bind to tubulin binding sites that differ from those found in guanosine-5'-triphosphate, podophyllotoxin, colchicine, and taxanes. KH Downing et al. (2000). Binding happens quickly and can sometimes go the other way. The data currently available supports two vinca alkaloid binding sites per mole of tubulin dimer(Correia JJ. et al., 2001). Each microtubule end has around 16-17 high-affinity binding locations. Vinca alkaloids bind to these sites, interrupting microtubule assembly; nonetheless, one of the most significant effects of small amounts of drug could be a reduction in the rates of microtubule development and shorten at the structure's end, resulting in a "kinetic cap" and functional suppression ( Ann Jordan M. et al., 1992). At lower pharmacological dosages than those that reduce microtubule mass, vinca alkaloids disrupt microtubule dynamics, specifically at the mitotic spindle's extremities, causing metaphase arrest (Toso RJ. et al., 1993). In vitro, vinca alkaloids and other microtubule-disrupting drugs can inhibit malignant angiogenesis. At dosages ranging from 0.1 to 1.0 pmol/L, VBL reduced endothelial proliferation, chemotaxis, and fibronectin spreading—all of which are essential processes in angiogenesis. At these low concentrations, normal fibroblasts and lymphoid malignancies were unaffected. Low dosages of VBL combined with vascular endothelial growth factor antibodies significantly increased the anticancer response, particularly in cancers resistant to the drug's direct cytotoxic effects (Klement G. et al., 2000). Vinca alkaloids inhibit cell division via attaching to microtubules, which may result in apoptosis and a mitotic halt. VCR and similar compounds destabilize microtubules by attaching to tubulin and preventing polymerization (Wang LG.et.al., 1999).

Biosynthesis of Vinca Alkaloids:

The biosynthesis of vincristine and vinblastine, two significant anticancer alkaloids made from tabersonine and catharanthine, is depicted in this image:
1. Using the T16H enzyme, tabersonine converts to 16-hydroxytabersonine, and using the 16OMT enzyme, it converts to 16-methoxytabersonine.
2. NMT enzyme ? desacetoxyvindoline ? deacetylvindoline ? vindoline (via DAT enzyme) ? 16-methoxytabersonine ? 16-methoxy-2,3-dihydro-3-hydroxytabersonine (by several stages).
3. 3',4'-anhydrovinblastine is created when vindoline and catharanthine interact (via the PRX1 enzyme).
4. After being transformed into vinblastine, 3',4'-anhydrovinblastine undergoes further modification to yield vincristine.Certain enzymes (e.g., T16H, 16OMT, PRX1) catalyze each step.

       
            Figure No. Biosynthetic pathway of Vinca Alkaloid.png
       
  

Figure No: Biosynthetic pathway of Vinca Alkaloid.

Cultivation and Collection of Alkaloids (Vinca):

It thrives at elevations up to 500 meters. Although this plant is distributed throughout India, it thrives in tropical and subtropical regions, such as the country's south and northeast. No specific kind of soil is needed for it. It thrives in light-sandy soil that has a high humus level. The ideal rainfall for its cultivation is 100 cm. It is propagated using the fresh seeds. Direct seeding is another option, however the seeds should be sown in the nursery. The seeds are sowed in rows with a 45-cm gap between each row after being combined with sand (1:10). The monsoon season is the ideal time to sow. When the plants have grown sufficiently, they are trimmed out. Otherwise, it is more cost-effective to seed in a nursery. In February or March, they are sowed in a nursery, and two months later, or when they reach a height of 6-7 cm, they are moved to an open field. The plants don't need a lot of water and can withstand drought. Additionally, the plants don't need any kind of fertilizer. Better outcomes are obtained with a combination of potassium, phosphorus, and nitrogen. Weeding is done occasionally and with the use of farmyard manures. After a year of growing, the stems are chopped. After being separated, the leaves, stems, and seeds are let to air dry. The process of digging out and then ploughing is used to gather the roots. After being thoroughly cleaned and allowed to dry in the shade, the roots are then packaged into bales. About 1 to 5 tons of roots, 1 to 2 tons of stems, and 3 to 4 tons of leaves are produced per hectare.

Extraction  and  Estimation of Vinca alkaloids:
       
            fig 1.png
       

Flowers of Catharanthus roseus G. Don. Catharanthus roseus (also known as Vinca rosea) is an evergreen shrub which grows to be 1 m tall and 1 m wide. The stem is short, erect, and branching; the leaves are shiny green, oval, 5 cm long, opposite, and acuminate; the blooms are soft pink, tinged with red, open, tubular, and 4 cm wide, appearing in spring as well as fall (three colors: pink, purple, along with white). (http://my.opera.com/Thachthaotim84/albums/showpic.dml) Because alkaloids are so important, researchers all across the world are exploring for new ways to extract and quantify them. Alkaloids were first extracted using paper chromatography (T.C. Tso et al., 1953). It was the simpler method for alkaloids to be extracted. This approach was quick and less expensive.  Thin layer chromatography was employed once more. Compared to paper chromatography, it had a low detection limit and was a repeatable procedure. The first HPLC method for alkaloid isolation was described by Wu and Wittick (C.Y. Wu. et al., 1977). Gas chromatography was first used to successfully estimate alkaloids by Brochmann-Hanssen and Svendsen (1962).  Other important approaches for alkaloid extraction include supercritical carbon dioxide extraction, ultrasound aided extraction, microwave assisted extraction (Q. Zhou et al., 2012) and the use of ultrasound and surfactants. PC, TLC, HPLC, and GC are the main chromatographic methods used for alkaloids determination (A. Djilani et al., 2006).

Vinca Alkaloids From Plants To Animals: The Evolutionary Link:

The metabolism as well as transport of vinca alkaloids in generating plant cells and treated mammalian cells illustrate some intriguing features of how evolution may be both sophisticated and frugal in the solutions it generates. Due to their exceptional biosynthesis ability, plants may generate a diverse range of substances that, while showing to play no role in essential processes of life (growth, development, as well as reproduction), seem to have vital functions as intermediaries of ecological relationships and are required for plant survival (MARIANA SOTTOMAYOR et al., 2006). The use of plants in medicine is dependent on their chemical riches, which is mostly unknown. Catharanthus roseus' terpenoid indole alkaloids, commonly known as Vinca alkaloids, are used in cancer treatment and are an example of a plant secondary metabolite. Plants produce vinca alkaloids via over 20 enzyme processes, including multiple cytochrome P450 monooxygenases along with a class III plant peroxidase. As has already been proven for a number of other plant secondary metabolites, we hypothesize that the transport mechanism responsible for the elimination of poisonous alkaloids through the cytoplasm into the vacuole of plant cells may be an ABC transporter. It is considered that the systems that control the metabolism as well as transportation of vinca alkaloids within animals evolved, at least in part, to guard against the poisonous substances found in the plants that animals consume (Gonzalez et al., 1990). Essential building blocks of such varied and dissimilar species as plants and animals have an early common ancestor, and during evolution, they were occasionally committed to tasks that are essentially hostile to one another. Toxic defensive chemicals in plants and xenobiotics in mammals share comparable processes for generation, accumulation, and metabolism. It is considered that the systems that control the metabolism as well as transport of vinca alkaloids in animals evolved, at least in part, to guard against the poisonous substances found in the plants that animals consume (Gonzalez et al., 1990). Essential building components of such varied and different species as animals and plants have a relatively recent common origin, and during their evolution, they were occasionally committed to actions that are essentially hostile to one another. Toxic defensive chemicals in plants and xenobiotics in mammals share comparable processes for generation, accumulation, and metabolism. Bacteria, fish, plants, and animals are all members of the ABC transporter superfamily, one of the biggest multigene groups. As a result of extensive duplication, single ancestral genes have evolved to perform a wide range of activities. Evolution has occasionally modified a small number of components to generate the biochemical survival strategies that are inherent in the astounding variety of life.

Medicinal Uses:
       
            fig 2.png
       

Toxicity:

The structural positions of the vinca alkaloids are very similar, however its toxicological profiles varies greatly. Although VCR has the greatest potential in this scenario, many vinca alkaloids induce varying degrees of peripheral neurotoxicity (Himes RH. et al., 1991). The primary characteristic of neurotoxicity is a peripheral, symmetric changeable sensory-motor, along with autonomic polyneuropathy. The main pathogenic outcomes are axonal degeneration and decreased axonal transport, which are most likely produced by drug-induced disruption of microtubule activity. The brain absorbs small amounts of VCR, and effects on the central nervous system including disorientation, changes in mental state, depression, hallucinations, agitation, insomnia, seizures, coma, syndrome, inappropriate antidiuretic hormone production, as well vision difficulties are uncommon. Furthermore, laryngeal paralysis was also reported. The only known effective therapies for vinca alkaloid neurotoxicity are lowering the dosage or frequency of drug administration or discontinuing therapy. Several antidotes have been used, including thiamine, vitamin B12, folinic acid, pyridoxine, and neuroactive medicines, although their efficiency has not been shown. All vinca alkaloids produce similar neurotoxicity symptoms, however severe neurotoxicity is less frequent with VBL and VRL than with VCR. The primary dose-limiting risk of VRL, VBL, and VDS is neutropenia. Anemia along with thrombocytopenia are often less common. Furthermore, VCR is seldom linked with hematologic toxicity; however, severe myelosuppression has been recorded in cases of significantly elevated drug exposure and hepatic insufficiency. Using vinca alkaloids may produce gastrointestinal toxicity in along with autonomic dysfunction (McGuire SA. et.al., 1989).  Most typically, VCR or high dosages of the other vinca alkaloids cause gastrointestinal autonomic dysfunction, which manifests as bloating, constipation, ileus, as well as abdominal pain. Mucositis is frequent with VCR, however more so with VBL than VRL. Nausea, vomiting, and diarrhea are all possibilities. Vinca alkaloids, as defined by Kufe DW. et al. (2003), are potent vesicants that can cause severe tissue damage. According to Hoffman et al. (1998), vinca alkaloids have also been linked to rapid cardiac ischemia, chest pains without ischemia-related symptoms, fever with no obvious cause, acute pulmonary effects, Raynaud phenomenon, hand-foot syndrome, as well as pulmonary and liver damage. Patients who are pregnant, planning to become pregnant, or nursing should avoid using these medications as they may cause birth defects. Patients ought to avoid getting vaccinated while using this medication. VCRs may weaken the immune system and induce illness. (Johnson IS. et al., 1963).  In addition to any other medical problems, such as chickenpox, herpes zoster infection, gout, kidney stones, infections, liver disease, or nerve or muscle damage, patients should inform their doctor about any prescription medicines they are taking while having chemotherapy. Overall, drug concentration and treatment time play a significant role in determining both drug accumulation and cytotoxicity; however, the evidence that is now available indicates that the most significant driver is the use of drugs above a critical threshold concentration. Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes, inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014)Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes, inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014) Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes, inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014 Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes, inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014 Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014 Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014 Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid

synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014 Alkaloids affect different metabolic systems in animals, and the toxic mechanism of action of alkaloids may vary considerably. Toxicity may arise by enzymatic alterations affecting physiological processes,

inhibition of DNA synthesis and repair mechanisms by intercalating with nucleic acids, or affecting the

nervous system. Several alkaloids may affect multiple functions (Mithöfer and Boland 2012). Taxines are calcium channel antagonists, increasing cytoplasmic calcium (Wilson et al. 2001). Pyrrolizidine alkaloid toxic effects are mainly due to their biotransformation into strong reactive pyrrole structures by oxidases from the mammalian liver. The reactive pyrroles act by alkylating nucleic acids and proteins (Cushnie et al. 2014). Alkaloid mechanisms of action as antibacterial agents differ among alkaloid classes. Synthetic quinolone alkaloids may have respiratory inhibition effects; isoquinolines, such as berberine, sanguinarine, protoberberine, and benzophenanthridine, inhibit cell division by

perturbing the Z-ring; the phenanthridine isoquinoline alkaloid ungeremine acts by inhibiting nucleic acid synthesis; pergularinine and tylophorinidine, which are indolizidine alkaloids, inhibit nucleic acid synthesis as well, by targeting dihydrofolate reductase (Cushnie et al. 2014

CONCLUSION:

Because of their special ability to alter microtubule dynamics and stop tumor growth, vinca alkaloids have become essential parts of cancer treatment. These substances, which are mostly derived from Catharanthus roseus, are prime examples of the medicinal potential of secondary metabolites found in plants. Their usage in a wide range of malignancies, including acute leukemias, breast cancer, and Hodgkin's lymphoma, proves their versatility and efficacy. Nonetheless, the related toxicities and adverse effects highlight the necessity of continued study to maximize their therapeutic index. New developments in combination medicines, targeted delivery methods, and synthetic changes present encouraging opportunities to increase their clinical usefulness while reducing side effects. This review emphasizes how crucial it is to combine ancient knowledge with contemporary research in order to develop and improve cancer treatment approaches.

CONFLICTS OF INTEREST:

There were no conflicts of interests reported.

ACKNOWLEDGEMENTS:

I would like to express my gratitude to Dr. Sandeep Patil Sir, Miss. Nikita Gurav Madam, Prof. Anuja Masule for their cooperation and help for making this review fruitful. Lastly, I would like to express gratitude to the Respected Principal Sir and Prof. Pankaj Jadhav, Mr. Iranna Gulagonda for their pivotal help in making this article successful by their bountiful knowledge                                             

REFERENCE

  1. Martino E, Casamassima G, Castiglione S, Cellupica E, Pantalone S, Papagni F, Rui M, Siciliano AM, Collina S. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. Bioorganic & medicinal chemistry letters. 2018 Sep 15;28(17):2816-26.
  2. Sottomayor M, Barceló AR. The Vinca alkaloids: from biosynthesis and accumulation in plant cells, to uptake, activity and metabolism in animal cells. Studies in Natural Products Chemistry. 2006 Jan 1;33:813-57.
  3. Zhang Y, Yang SH, Guo XL. New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer. Biomedicine & pharmacotherapy. 2017 Dec 1;96:659-66.
  4. Sharifi-Rad J, Quispe C, Butnariu M, Rotariu LS, Sytar O, Sestito S, Rapposelli S, Akram M, Iqbal M, Krishna A, Kumar NV. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer cell international. 2021 Jun 24;21(1):318.
  5. Mitrut P, Docea AO, Kamal AM, Mitrut R, Calina D, Gofita E, Padureanu V, Gruia C, Streba L. Colorectal cancer and inflammatory bowel disease. Colorectal Cancer-from Pathogenesis to Treatment, L. Rodrigo, Ed. 2016 Sep 7:185-99.
  6. Zlatian OM, Comanescu MV, Rosu AF, Rosu L, Cruce M, Gaman AE, Calina CD, Sfredel V. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer. Rom J Morphol Embryol. 2015 Jan 1;56(1):175-81.
  7. Buga AM, Docea AO, Albu C, Malin RD, Branisteanu DE, Ianosi G, Ianosi SL, Iordache A, Calina D. Molecular and cellular stratagem of brain metastases associated with melanoma. Oncology Letters. 2019 May 1;17(5):4170-5.
  8. Zijlstra A, Von Lersner A, Yu D, Borrello L, Oudin M, Kang Y, Sahai E, Fingleton B, Stein U, Cox TR, Price JT. The importance of developing therapies targeting the biological spectrum of metastatic disease. Clinical & experimental metastasis. 2019 Aug 15;36:305-9.
  9. Wild CP, Weiderpass E, Stewart BW. World cancer report.
  10. Sani TA, Mohammadpour E, Mohammadi A, Memariani T, Yazdi MV, Rezaee R, Calina D, Docea AO, Goumenou M, Etemad L, Shahsavand S. Cytotoxic and apoptogenic properties of Dracocephalum kotschyi aerial part different fractions on calu-6 and mehr-80 lung cancer cell lines. Farmacia. 2017 Mar 1;65(2).
  11. Hossain R, Quispe C, Herrera-Bravo J, Islam MS, Sarkar C, Islam MT, Martorell M, Cruz-Martins N, Al-Harrasi A, Al-Rawahi A, Sharifi-Rad J. Lasia spinosa chemical composition and therapeutic potential: A literature?based review. Oxidative Medicine and Cellular Longevity. 2021;2021(1):1602437.
  12. Astani A, Reichling J, Schnitzler P. Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro. Chemotherapy. 2012 Mar 1;58(1):70-7.
  13. Sharifi-Rad J, Quispe C, Imran M, Rauf A, Nadeem M, Gondal TA, Ahmad B, Atif M, Mubarak MS, Sytar O, Zhilina OM. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxidative medicine and cellular longevity. 2021;2021(1):3268136.
  14. Kato Y, Maeda T, Suzuki A, Baba Y. Cancer metabolism: new insights into classic characteristics. Japanese Dental Science Review. 2018 Feb 1;54(1):8-21.
  15. Islam MT, Quispe C, El-Kersh DM, Shill MC, Bhardwaj K, Bhardwaj P, Sharifi-Rad J, Martorell M, Hossain R, Al-Harrasi A, Al-Rawahi A. A literature?based update on Benincasa hispida (Thunb.) Cogn.: Traditional uses, nutraceutical, and phytopharmacological profiles. Oxidative medicine and cellular longevity. 2021;2021(1):6349041.
  16. Salehi B, Sestito S, Rapposelli S, Peron G, Calina D, Sharifi-Rad M, Sharopov F, Martins N, Sharifi-Rad J. Epibatidine: a promising natural alkaloid in health. Biomolecules. 2018 Dec 23;9(1):6.
  17. Gonzalez, F.J.; Nebert, D.W.; Trends Genet., 1990, 6,182-186.
  18. Danielson, P.B.; Cur. Drug Metabol, 2002, 3, 561-597.
  19. Hughes, A.L. Mol. Biol. Evol, 1994,11, 899-910.
  20. Martinoia, E.; Klein, M.; Geisler, M.; Bovet, L.; Forestier, C; Kolukisaoglu, U.; MuUer-Rober, B.; Schultz, B.; Planta, 2002, 214, 345-355.
  21. Dean, M.; Hamon, Y.; Chimini, G.; J. Lip Res., 2001, 42, 1007- 1017.
  22. Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, et al. 6th ed. Hamilton (ON): BC Decker Inc; 2003. Holland-Frei cancer medicine.
  23. Rowinsky EK, Donehower RC. Paclitaxel (taxol). New England journal of medicine. 1995 Apr 13;332(15):1004-14.
  24. Gregory RK, Smith IE. Vinorelbine–a clinical review. British journal of cancer. 2000 Jun;82(12):1907-13.
  25. Joel S. The comparative clinical pharmacology of vincristine and vindesine: does vindesine offer any advantage in clinical use?. Cancer treatment reviews. 1995 Nov 1;21(6):513-25.
  26. Schutz FA, Bellmunt J, Rosenberg JE, Choueiri TK. Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid. Expert opinion on drug safety. 2011 Jul 1;10(4):645-53.
  27. Bennouna J, Delord JP, Campone M, Nguyen L. Vinflunine: a new microtubule inhibitor agent. Clinical cancer research. 2008 Mar 15;14(6):1625-32.
  28. Himes RH. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules. Pharmacology & therapeutics. 1991 Jan 1;51(2):257-67.
  29. McGuire SA, Gospe Jr SM, Dahl G. Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I. Medical and pediatric oncology. 1989;17(5?6):520-3.
  30. Hoff PM, Valero V, Ibrahim N, Willey J, Hortobagyi GN. Hand?foot syndrome following prolonged infusion of high doses of vinorelbine. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1998 Mar 1;82(5):965-9.
  31. Johnson IS, Armstrong JG, Gorman M, Burnett Jr JP. The vinca alkaloids: a new class of oncolytic agents. Cancer research. 1963 Sep 1;23(8_Part_1):1390-427.
  32. Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annual review of cell and developmental biology. 2000 Nov;16(1):89-111.
  33. Correia JJ, Lobert S. Physiochemical aspects of tubulin-interacting antimitotic drugs. Current pharmaceutical design. 2001 Sep 1;7(13):1213-28.
  34. Ann Jordan M, Thrower D, Wilson L. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles: implications for the role of microtubule dynamics in mitosis. Journal of cell science. 1992 Jul 1;102(3):401-16.
  35. Toso RJ, Jordan MA, Farrell KW, Matsumoto B, Wilson L. Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine. Biochemistry. 1993 Feb 1;32(5):1285-93.
  36. Wang LG, Liu XM, Kreis W, Budman DR. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer chemotherapy and pharmacology. 1999 Sep;44:355-61.
  37. Dey P, Kundu A, Kumar A, Gupta M, Lee BM, Bhakta T, Dash S, Kim HS. Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids). InRecent advances in natural products analysis 2020 Jan 1 (pp. 505-567). Elsevier.
  38. Brogan C. Alkaloids cancer treatments [Internet]. 2010.

Reference

  1. Martino E, Casamassima G, Castiglione S, Cellupica E, Pantalone S, Papagni F, Rui M, Siciliano AM, Collina S. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. Bioorganic & medicinal chemistry letters. 2018 Sep 15;28(17):2816-26.
  2. Sottomayor M, Barceló AR. The Vinca alkaloids: from biosynthesis and accumulation in plant cells, to uptake, activity and metabolism in animal cells. Studies in Natural Products Chemistry. 2006 Jan 1;33:813-57.
  3. Zhang Y, Yang SH, Guo XL. New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer. Biomedicine & pharmacotherapy. 2017 Dec 1;96:659-66.
  4. Sharifi-Rad J, Quispe C, Butnariu M, Rotariu LS, Sytar O, Sestito S, Rapposelli S, Akram M, Iqbal M, Krishna A, Kumar NV. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer cell international. 2021 Jun 24;21(1):318.
  5. Mitrut P, Docea AO, Kamal AM, Mitrut R, Calina D, Gofita E, Padureanu V, Gruia C, Streba L. Colorectal cancer and inflammatory bowel disease. Colorectal Cancer-from Pathogenesis to Treatment, L. Rodrigo, Ed. 2016 Sep 7:185-99.
  6. Zlatian OM, Comanescu MV, Rosu AF, Rosu L, Cruce M, Gaman AE, Calina CD, Sfredel V. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer. Rom J Morphol Embryol. 2015 Jan 1;56(1):175-81.
  7. Buga AM, Docea AO, Albu C, Malin RD, Branisteanu DE, Ianosi G, Ianosi SL, Iordache A, Calina D. Molecular and cellular stratagem of brain metastases associated with melanoma. Oncology Letters. 2019 May 1;17(5):4170-5.
  8. Zijlstra A, Von Lersner A, Yu D, Borrello L, Oudin M, Kang Y, Sahai E, Fingleton B, Stein U, Cox TR, Price JT. The importance of developing therapies targeting the biological spectrum of metastatic disease. Clinical & experimental metastasis. 2019 Aug 15;36:305-9.
  9. Wild CP, Weiderpass E, Stewart BW. World cancer report.
  10. Sani TA, Mohammadpour E, Mohammadi A, Memariani T, Yazdi MV, Rezaee R, Calina D, Docea AO, Goumenou M, Etemad L, Shahsavand S. Cytotoxic and apoptogenic properties of Dracocephalum kotschyi aerial part different fractions on calu-6 and mehr-80 lung cancer cell lines. Farmacia. 2017 Mar 1;65(2).
  11. Hossain R, Quispe C, Herrera-Bravo J, Islam MS, Sarkar C, Islam MT, Martorell M, Cruz-Martins N, Al-Harrasi A, Al-Rawahi A, Sharifi-Rad J. Lasia spinosa chemical composition and therapeutic potential: A literature?based review. Oxidative Medicine and Cellular Longevity. 2021;2021(1):1602437.
  12. Astani A, Reichling J, Schnitzler P. Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro. Chemotherapy. 2012 Mar 1;58(1):70-7.
  13. Sharifi-Rad J, Quispe C, Imran M, Rauf A, Nadeem M, Gondal TA, Ahmad B, Atif M, Mubarak MS, Sytar O, Zhilina OM. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxidative medicine and cellular longevity. 2021;2021(1):3268136.
  14. Kato Y, Maeda T, Suzuki A, Baba Y. Cancer metabolism: new insights into classic characteristics. Japanese Dental Science Review. 2018 Feb 1;54(1):8-21.
  15. Islam MT, Quispe C, El-Kersh DM, Shill MC, Bhardwaj K, Bhardwaj P, Sharifi-Rad J, Martorell M, Hossain R, Al-Harrasi A, Al-Rawahi A. A literature?based update on Benincasa hispida (Thunb.) Cogn.: Traditional uses, nutraceutical, and phytopharmacological profiles. Oxidative medicine and cellular longevity. 2021;2021(1):6349041.
  16. Salehi B, Sestito S, Rapposelli S, Peron G, Calina D, Sharifi-Rad M, Sharopov F, Martins N, Sharifi-Rad J. Epibatidine: a promising natural alkaloid in health. Biomolecules. 2018 Dec 23;9(1):6.
  17. Gonzalez, F.J.; Nebert, D.W.; Trends Genet., 1990, 6,182-186.
  18. Danielson, P.B.; Cur. Drug Metabol, 2002, 3, 561-597.
  19. Hughes, A.L. Mol. Biol. Evol, 1994,11, 899-910.
  20. Martinoia, E.; Klein, M.; Geisler, M.; Bovet, L.; Forestier, C; Kolukisaoglu, U.; MuUer-Rober, B.; Schultz, B.; Planta, 2002, 214, 345-355.
  21. Dean, M.; Hamon, Y.; Chimini, G.; J. Lip Res., 2001, 42, 1007- 1017.
  22. Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, et al. 6th ed. Hamilton (ON): BC Decker Inc; 2003. Holland-Frei cancer medicine.
  23. Rowinsky EK, Donehower RC. Paclitaxel (taxol). New England journal of medicine. 1995 Apr 13;332(15):1004-14.
  24. Gregory RK, Smith IE. Vinorelbine–a clinical review. British journal of cancer. 2000 Jun;82(12):1907-13.
  25. Joel S. The comparative clinical pharmacology of vincristine and vindesine: does vindesine offer any advantage in clinical use?. Cancer treatment reviews. 1995 Nov 1;21(6):513-25.
  26. Schutz FA, Bellmunt J, Rosenberg JE, Choueiri TK. Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid. Expert opinion on drug safety. 2011 Jul 1;10(4):645-53.
  27. Bennouna J, Delord JP, Campone M, Nguyen L. Vinflunine: a new microtubule inhibitor agent. Clinical cancer research. 2008 Mar 15;14(6):1625-32.
  28. Himes RH. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules. Pharmacology & therapeutics. 1991 Jan 1;51(2):257-67.
  29. McGuire SA, Gospe Jr SM, Dahl G. Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I. Medical and pediatric oncology. 1989;17(5?6):520-3.
  30. Hoff PM, Valero V, Ibrahim N, Willey J, Hortobagyi GN. Hand?foot syndrome following prolonged infusion of high doses of vinorelbine. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1998 Mar 1;82(5):965-9.
  31. Johnson IS, Armstrong JG, Gorman M, Burnett Jr JP. The vinca alkaloids: a new class of oncolytic agents. Cancer research. 1963 Sep 1;23(8_Part_1):1390-427.
  32. Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annual review of cell and developmental biology. 2000 Nov;16(1):89-111.
  33. Correia JJ, Lobert S. Physiochemical aspects of tubulin-interacting antimitotic drugs. Current pharmaceutical design. 2001 Sep 1;7(13):1213-28.
  34. Ann Jordan M, Thrower D, Wilson L. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles: implications for the role of microtubule dynamics in mitosis. Journal of cell science. 1992 Jul 1;102(3):401-16.
  35. Toso RJ, Jordan MA, Farrell KW, Matsumoto B, Wilson L. Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine. Biochemistry. 1993 Feb 1;32(5):1285-93.
  36. Wang LG, Liu XM, Kreis W, Budman DR. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer chemotherapy and pharmacology. 1999 Sep;44:355-61.
  37. Dey P, Kundu A, Kumar A, Gupta M, Lee BM, Bhakta T, Dash S, Kim HS. Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids). InRecent advances in natural products analysis 2020 Jan 1 (pp. 505-567). Elsevier.
  38. Brogan C. Alkaloids cancer treatments [Internet]. 2010.

Photo
Satyam Ambardekar
Corresponding author

Appasaheb Birnale College of Pharmacy, B.pharm , Sangli

Photo
Sandeep Patil
Co-author

Dr. Shivajirao Kadam College of Pharmacy, Sangli

Photo
Nikita Gurav
Co-author

Dr. Shivajirao Kadam College of Pharmacy, Sangli

Photo
Shahista Mujawar
Co-author

Dr. Shivajirao Kadam College of Pharmacy, Sangli

Satyam Ambardekar*, Sandeep Patil, Nikita Gurav, Shahista Mujawar, Vinca Alkaloids in Cancer Therapy: Mechanisms, Biosynthesis, and Advances in Therapeutic Applications, Int. J. Sci. R. Tech., 2025, 2 (1), 298-314. https://doi.org/10.5281/zenodo.14695718

More related articles
Nanomedicine based approaches on mRNA delivery ...
Pawan Hadole , Nikam H. M, Avinash Gite, Pratik Kamble, Umesh Jad...
Assessment of Water Quality and Pollution Impact o...
Reddy P. B., Bhawna Srivastava, Virendra Kushwah, ...
A Review on Vitamin B 17 (Amygdalin)...
Praveen Kumar Dasari, Kumar Raja Jayavarapu, P. Prem Kumar, G. Du...
Microspheres as A Multiparticulate Drug Delivery Systems: A Comprehensive Review...
Prajval Birajdar, Dr. Amol Borade, Ashwini Karnakoti, Kartik Shinde, Mangesh Dagale, Vishal Bodke, ...
Transforming Wayang-Based Short Stories into Film Screenplays...
Rima Firdaus, Nuri Hermawan, Lady Khairunnisa, Nadya Afdholy, Mochtar Lutfi, Rizal Agung Kurnia, ...
Effect Of Milk and Water Kefir Granules in Sugar Solution...
Rongali Indu, Dr. M. Savitri, M. Swapna, B. Rama Madhuri, Dr. P. Uma Devi, ...
Related Articles
A Review on Thuja Plant Species...
Sakshi Shejwal , Vrushali Baisane , Pritam Sawant, Sanika Chavan, Priya Salunke, ...
The Medicinal Attributes of Delonix regia: An Exploratory Study of its Bioactive...
Arshin Solomon, Pragya Pandey , Faith Ruth Dixon, Meghna Singh, Aaron Dogba Yassah, Arnab Roy , ...
Alopathy Drug Used Treatment for Tuberculosis (Tb)...
Sarthak Mote , Gurud Tejaswini, Sayyad kaifali adam, Ajim Shaikh, Sachin Sapkal, Galgate K. M., Swap...
A Review on Vitiligo A Chronic Skin Disorder...
Abhishek Bhosale, Sneha Kanase, Swapnil Wadkar, Akash Balid, Sanket Fulari, Naman Gandhi, Sagar Kale...
Nanomedicine based approaches on mRNA delivery ...
Pawan Hadole , Nikam H. M, Avinash Gite, Pratik Kamble, Umesh Jadhav, ...
More related articles
Nanomedicine based approaches on mRNA delivery ...
Pawan Hadole , Nikam H. M, Avinash Gite, Pratik Kamble, Umesh Jadhav, ...
A Review on Vitamin B 17 (Amygdalin)...
Praveen Kumar Dasari, Kumar Raja Jayavarapu, P. Prem Kumar, G. Durga, Y. Shiva Bhavani, D. Kyathi Le...
Nanomedicine based approaches on mRNA delivery ...
Pawan Hadole , Nikam H. M, Avinash Gite, Pratik Kamble, Umesh Jadhav, ...
A Review on Vitamin B 17 (Amygdalin)...
Praveen Kumar Dasari, Kumar Raja Jayavarapu, P. Prem Kumar, G. Durga, Y. Shiva Bhavani, D. Kyathi Le...